Amyloid β-Peptide Aβ1−42 But Not Aβ1−40 Attenuates Synaptic AMPA Receptor Function


    loading  Checking for direct PDF access through Ovid

Abstract

ABSTRACTThe brains of Alzheimer's disease (AD) patients have large numbers of plaques that contain amyloid beta (Aβ) peptides which are believed to play a pivotal role in AD pathology. Several lines of evidence have established the inhibitory role of Aβ peptides on hippocampal memory encoding, a process that relies heavily on αamino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function. In this study the modulatory effects of the two major Aβ peptides, Aβ1−40 and Aβ1−42, on synaptic AMPA receptor function was investigated utilizing the whole cell patch clamp technique and analyses of single channel properties of synaptic AMPA receptors. Bath application of Aβ1−42 but not Aβ1−40 reduced both the amplitude and frequency of AMPA receptor mediated excitatory postsynaptic currents in hippocampal CA1 pyramidal neurons by ∽60% and ∽45%, respectively, in hippocampal CA1 pyramidal neurons. Furthermore, experiments with single synaptic AMPA receptors reconstituted in artificial lipid bilayers showed that Aβ1−42 reduced the channel open probability by ∽42% and channel open time by ∽65% and increased the close times by several fold. Aβ1−40, however, did not show such inhibitory effects on single channel properties. Application of the reverse sequence peptide Aβ42−1 also did not alter the mEPSC or single channel properties. These results suggest that Aβ1−42 but not Aβ1−40 closely interacts with and exhibits inhibitory effects on synaptic AMPA receptors and may contribute to the memory impairment observed in AD.

    loading  Loading Related Articles